Align vs Schiff Digestive Advantage (2026): Strains Compared
Informational comparison of label data, cost, and published clinical evidence — not medical advice. Talk to your doctor before choosing a probiotic for a specific condition. Prices are live per-serving figures; strain and CFU data are each brand's published label.
These are studied for different IBS subtypes, not different strengths. Align (1 billion CFU B. infantis 35624, $0.96/day) has a large trial (n=362) for general IBS symptoms: pain, bloating, and bowel habit.
Schiff Digestive Advantage (2 billion CFU B. coagulans BC30, $0.35/day) has a smaller trial (n=44) specifically in IBS-D, plus separate evidence for vaccine antibody response. Neither carries third-party certification.
The numbers, side by side
| Per serving | Align Probiotic | Schiff Digestive Advantage |
|---|---|---|
| Strain | B. infantis 35624 | B. coagulans BC30 (GBI-30, 6086) |
| Count | 1 billion CFU | 2 billion CFU |
| Serving size | 1 capsule | 1 capsule |
| Servings/container | 28 | 80 |
| Spore-forming | No | Yes — survives stomach acid, no refrigeration needed |
| Third-party cert | None | None |
| Condition-specific evidence on file | IBS symptoms — pain, bloating, bowel habit (RCT, n=362) | IBS-D — abdominal pain and bloating (RCT, n=44); separate vaccine-antibody-response finding |
| Price | $26.86 | $24.00 |
| Cost / day | $0.96 | $0.29 |
Prices are live Amazon buy-box figures divided into a daily cost; they move. Strain and serving data are each brand's published label.
The real difference: which IBS subtype, not which is "stronger"
It's tempting to read 2 billion CFU as double the strength of 1 billion. That's not how strain-specific evidence works. Align's 1 billion CFU dose was the effective dose in its own trial. A 10 billion CFU dose of the same strain wasn't more effective.
Schiff's 2 billion CFU of B. coagulans BC30 is a different organism entirely. It was studied in a smaller trial (n=44), specifically in IBS-D, the diarrhea-predominant subtype.
So the real question isn't which product has more CFU. It's which trial matches your symptoms. Align's evidence covers general IBS symptoms: pain, bloating, and bowel habit satisfaction, in a much larger study population.
Schiff's evidence is narrower, but specific to diarrhea-predominant IBS. It also carries a separate finding: enhanced antibody response to flu vaccination in its own trial.
Who each one is for
Choose Align if you have general IBS symptoms: bloating, abdominal pain, irregular bowel habits, without diarrhea as the dominant symptom. It's the larger, more general trial of the two.
Choose Schiff Digestive Advantage if your IBS is diarrhea-predominant (IBS-D), or you want a shelf-stable, spore-forming strain at a lower cost per day. It's also the pick if you want the added vaccine-response evidence.
Choose neither if you're buying "for gut health" with no specific condition in mind — see the full evidence rundown and the American Gastroenterological Association's guidance against generic probiotic use before spending on either.
Our picks
1 billion CFU B. infantis 35624. RCT, n=362, $0.96/day.
2 billion CFU B. coagulans BC30, spore-forming. RCT, n=44, $0.29/day.
As an Amazon Associate we earn from qualifying purchases. We rank by verified label data, strain-condition evidence, and cost per day, never commissions.
Frequently asked questions
Is Align or Schiff Digestive Advantage better for IBS?
It depends on your IBS subtype. Align's trial (n=362) tested general IBS symptoms — pain, bloating, and bowel habit satisfaction. Schiff's trial (n=44) was specifically in IBS-D, the diarrhea-predominant subtype. If you have IBS-D, Schiff's evidence is the closer match; for general IBS symptoms, Align has the larger trial behind it.
Why does Align contain less CFU than Schiff Digestive Advantage?
Because 1 billion CFU was the effective dose in Align's own trial. The same study tested a 10 billion CFU dose of B. infantis 35624, and it was not more effective. CFU counts also don't compare across different strains — Schiff's 2 billion CFU of B. coagulans BC30 is a different organism entirely, not a stronger version of the same one.
Is Schiff Digestive Advantage good for immune support too?
A separate trial found that B. coagulans BC30 (the strain in Schiff Digestive Advantage) enhanced antibody response to flu vaccination. That's a different use case from its IBS-D evidence, and it's not documented for Align's strain here.
Which is cheaper, and does the price gap matter?
Schiff Digestive Advantage costs $0.35/day versus Align's $0.96/day — roughly a third the price. Most of that gap comes from Schiff's 80-serving container against Align's 28. Neither product carries third-party certification, so the price difference doesn't reflect a verification gap.
Related
- Best probiotic for IBS — the full B. infantis and B. coagulans evidence
- Best probiotic overall — ranked by what you're treating, all six conditions
- Seed vs Culturelle — a different strain-vs-strain comparison
- Probiotics dosage guide — why strain beats CFU count
Sources
- Whorwell PJ, et al. "Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome." Am J Gastroenterol. 2006. PMID: 16863564
- Hun L. "Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS." Postgrad Med. 2009. PMID: 19332970
- Kimmel M, et al. "A controlled trial of Bacillus coagulans (GanedenBC30) to enhance immune response to influenza vaccination." Postgrad Med. 2010.
- Product labels: Align Probiotic, Schiff Digestive Advantage, manufacturer label/site data, July 2026.